John Castle
Direttore Tecnico/Scientifico/R&S presso MONTE ROSA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Andrew Schiff | M | 58 | 4 anni | |
| Markus Warmuth | M | 53 | 4 anni | |
| Ulf Arne Wiinberg | M | 66 | 8 anni | |
| Sharon Townson | M | 49 | 4 anni | |
| Alexander Mayweg | M | 49 | 6 anni | |
| Kimberly Blackwell | M | 55 | 4 anni | |
| Iraj Ali | M | 48 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 6 anni |
| Sierk Poetting | M | 51 | 10 anni | |
| Jennifer Champoux | F | - | 3 anni | |
| Jan Skvarka | M | 57 | 1 anni | |
| Allison Jeynes-Ellis | M | 58 | 6 anni | |
| Anthony Manning | M | 62 | 1 anni | |
| Ali Behbahani | M | 48 | 4 anni | |
| Chandra Paul Leo | M | 53 | 4 anni | |
| Christine Siu | F | 47 | 4 anni | |
| Alfred Dadson | M | - | 8 anni | |
| Sean Marett | M | 59 | 12 anni | |
| Filip Janku | M | 50 | 3 anni | |
| Philip Nickson | M | 45 | 3 anni | |
| Michael Rapé | M | - | 4 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Shalini Sharp | F | 49 | 15 anni | |
| Karen Valentine | F | 52 | 14 anni | |
| Ozer Baysal | M | 68 | - | |
| Jean-Marie Cuillerot | M | - | 2 anni | |
| Christian Cortis | M | - | - | |
| Mohammed Malik | M | 56 | 3 anni | |
| Michael Kring | M | 52 | 5 anni | |
| Tom Dechaene | M | 64 | 16 anni | |
| Donald Vidic | M | - | 2 anni | |
| Owen Wallace | M | 55 | 3 anni | |
| Paulo Moreira | M | - | 2 anni | |
| Anna Wijatyk | M | - | - | |
| Sunil Gupta | M | - | - | |
| Michael Plater | M | - | 1 anni | |
| James Gorman | M | - | - | |
| Charles Ballantyne | M | 64 | 1 anni | |
| Min Wang | M | - | 1 anni | |
| Jane Robertson | M | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 4 anni |
| Ernest Shingyan Wong | M | 56 | - | |
| Jullian Jones | M | - | - | |
| Marc van Dijk | M | 61 | - | |
| Ajim Tamboli | M | 47 | 3 anni | |
| Alexander Duncan | M | 62 | 5 anni | |
| Justin Zelin | M | - | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 39 | 88.64% |
| Germania | 3 | 6.82% |
| Regno Unito | 2 | 4.55% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- John Castle
- Contatti personali
